SK14112000A3 - Začlenenie účinných látok do matríc nosiča - Google Patents

Začlenenie účinných látok do matríc nosiča Download PDF

Info

Publication number
SK14112000A3
SK14112000A3 SK1411-2000A SK14112000A SK14112000A3 SK 14112000 A3 SK14112000 A3 SK 14112000A3 SK 14112000 A SK14112000 A SK 14112000A SK 14112000 A3 SK14112000 A3 SK 14112000A3
Authority
SK
Slovakia
Prior art keywords
aqueous phase
emulsion
active substance
carrier
emulsifying agent
Prior art date
Application number
SK1411-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Marie-Louise Andersson
Catherine Boissier
Anne Marie Juppo
Anette Larsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK14112000A3 publication Critical patent/SK14112000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Nozzles (AREA)
SK1411-2000A 1998-04-14 1999-04-09 Začlenenie účinných látok do matríc nosiča SK14112000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes
PCT/SE1999/000583 WO1999052507A1 (fr) 1998-04-14 1999-04-09 Incorporation de substances actives dans des matrices porteuses

Publications (1)

Publication Number Publication Date
SK14112000A3 true SK14112000A3 (sk) 2001-07-10

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1411-2000A SK14112000A3 (sk) 1998-04-14 1999-04-09 Začlenenie účinných látok do matríc nosiča

Country Status (31)

Country Link
US (1) US6372260B1 (fr)
EP (1) EP1069890B1 (fr)
JP (1) JP2002511400A (fr)
KR (1) KR100600691B1 (fr)
CN (1) CN1201728C (fr)
AR (1) AR019262A1 (fr)
AT (1) ATE329580T1 (fr)
AU (1) AU744874B2 (fr)
BR (1) BR9909636A (fr)
CA (1) CA2327522C (fr)
CY (1) CY1105154T1 (fr)
CZ (1) CZ20003784A3 (fr)
DE (1) DE69931904T2 (fr)
DK (1) DK1069890T3 (fr)
EE (1) EE200000595A (fr)
ES (1) ES2267268T3 (fr)
HU (1) HUP0102305A3 (fr)
ID (1) ID29286A (fr)
IL (1) IL138635A0 (fr)
IS (1) IS5656A (fr)
NO (1) NO329145B1 (fr)
NZ (1) NZ507190A (fr)
PL (1) PL344077A1 (fr)
PT (1) PT1069890E (fr)
RU (1) RU2208435C2 (fr)
SE (1) SE9801287D0 (fr)
SK (1) SK14112000A3 (fr)
TR (1) TR200002960T2 (fr)
TW (1) TW542724B (fr)
WO (1) WO1999052507A1 (fr)
ZA (1) ZA992549B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
AU2729101A (en) * 1999-12-21 2001-07-03 Rxkinetix, Inc. Particulate drug-containing products and method of manufacture
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
EP1429802B1 (fr) * 2001-09-28 2012-11-07 TNTGamble, Inc. Systeme de distribution de composant biologique
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US6931888B2 (en) 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
EP1624862B1 (fr) 2003-05-08 2014-12-31 Nektar Therapeutics Materiaux particulaires
WO2005022603A2 (fr) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Contenants conducteurs economiques fabriques a partir de materiaux a base de resine chargee d'elements conducteurs
GB0602637D0 (en) 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
US20080095856A1 (en) * 2006-05-12 2008-04-24 Jacobson Gunilla B Encapsulated Nanoparticles for Drug Delivery
FR2900845B1 (fr) * 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (fr) 2006-10-19 2008-04-23 Gerhard, Markus Nouveau méthode pour le traitement des infections par H. pylori
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
EP2120875B1 (fr) 2007-02-11 2018-07-11 Map Pharmaceuticals Inc. Procédé d'administration thérapeutique de dhe pour procurer un soulagement rapide de la migraine tout en minimisant le profil des effets secondaires
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (fr) 2016-07-20 2018-01-24 Technische Universität München Agents et procédés de prévention ou de traitement d'infections à h. pylori
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639441A (en) 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
DE69931904T2 (de) 2006-12-21
TW542724B (en) 2003-07-21
ATE329580T1 (de) 2006-07-15
WO1999052507A1 (fr) 1999-10-21
ES2267268T3 (es) 2007-03-01
SE9801287D0 (sv) 1998-04-14
IL138635A0 (en) 2001-10-31
EP1069890B1 (fr) 2006-06-14
AR019262A1 (es) 2002-02-13
HUP0102305A3 (en) 2003-04-28
TR200002960T2 (tr) 2000-12-21
CA2327522C (fr) 2008-03-25
AU744874B2 (en) 2002-03-07
NZ507190A (en) 2002-02-01
CY1105154T1 (el) 2010-03-03
KR20010042660A (ko) 2001-05-25
DE69931904D1 (de) 2006-07-27
BR9909636A (pt) 2000-12-19
NO20005150D0 (no) 2000-10-13
KR100600691B1 (ko) 2006-07-19
HUP0102305A2 (hu) 2001-12-28
PT1069890E (pt) 2006-09-29
PL344077A1 (en) 2001-09-24
JP2002511400A (ja) 2002-04-16
CN1201728C (zh) 2005-05-18
DK1069890T3 (da) 2006-08-28
ID29286A (id) 2001-08-16
ZA992549B (en) 1999-10-14
US6372260B1 (en) 2002-04-16
EP1069890A1 (fr) 2001-01-24
AU4066399A (en) 1999-11-01
NO329145B1 (no) 2010-08-30
IS5656A (is) 2000-10-11
CZ20003784A3 (cs) 2001-08-15
EE200000595A (et) 2002-04-15
CA2327522A1 (fr) 1999-10-21
RU2208435C2 (ru) 2003-07-20
CN1309555A (zh) 2001-08-22
NO20005150L (no) 2000-12-08

Similar Documents

Publication Publication Date Title
SK14112000A3 (sk) Začlenenie účinných látok do matríc nosiča
AU746337B2 (en) Methods for fabricating polymer-based controlled release preparations
Tamber et al. Formulation aspects of biodegradable polymeric microspheres for antigen delivery
DE60130917T2 (de) Induziertes phasenübergangsverfahren zur herstellung von hydrophile wirkstoffe enthaltenden mikropartikeln
CA2193203C (fr) Microparticules de polymere destinees a l'apport des medicaments
EP1033973B1 (fr) Procede d'encapsulage
EP0737472A1 (fr) Formulation de vaccin pour une administration unique
US6080429A (en) Method for drying microspheres
AU2002343681A1 (en) Biocompatible polymer blends and uses thereof
WO2003041689A1 (fr) Melanges de polymeres biocompatibles et leur utilisation
WO1995011009A1 (fr) Procede de preparation de microspheres avec etape de sechage en lit fluidise
JP2004517146A (ja) 生物活性物質カプセル化生分解性高分子の微粒子および該微粒子を含有する徐放性医薬配合物
MXPA00009914A (en) Incorporation of active substances in carrier matrixes
JPH09132524A (ja) 徐放性製剤の製造法
WO2001058428A1 (fr) Procede de preparation d'une composition a liberation prolongee
MXPA96000938A (en) Single application vaccination formulation